For many years, we have been told that aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) could reduce the risk of cancer.
However, it was never really scientifically explained or understood why this was, although researchers suggested the drugs could reduce death rates in multiple types of cancer by as much as 20%.
A recent study published in the journal PLOS Genetics suggests that the drug slows the accumulation of a type of DNA change called “somatic genome abnormalities” (S.G.A.’s). The production of this type of DNA leads to uncontrollable cell growth and makes it very hard for the process to be reversed, especially if it is not treated early.
The study consisted of 13 participants with a condition called Barrett’s Esophagus, which causes damage to the cells in the esophagus, usually by acid reflux. These participants were tracked for 12 years to check the process of mutations of the condition.
There was a 90% reduction rate in the rate of mutations. This is considered a high success rate, however, it is important to note that the study was done on a very small population and would need to be tested over a larger population to determine more concrete answers.
It is also important to be aware of the fact that this study is only suggesting that these drugs can slow down cancerous cell growth, not treat nor cure any type of cancer or disease. Although the use of these drugs may not stop cancer completely, it can most likely add a extra years to the life of one suffering from the disease.
Nonetheless, the findings are interesting and worth looking further into. A link to the study is provided below.
Source: Link to the study